CGNX Cognex Corporation (NASDAQ) $58.79 Feb 16 2026: AI demand lifts margins

CGNX stock is trading at $58.79 intraday on 16 Feb 2026 after a Q4 beat and upbeat guidance. The company reported revenue $252.34 million and EPS $0.27, topping consensus and lifting margin expectations. Volume has surged to 4,792,062 shares versus an average of 1,946,524, showing strong active interest. Investors are now weighing elevated valuation against improving cash flow and an AI-driven product cycle.

Q4 results and guidance: earnings beat drives momentum

Cognex Corporation (CGNX) posted Q4 revenue of $252.34 million, up 9.9% year-over-year, and EPS of $0.27, beating analyst estimates. Management raised near-term guidance and flagged margin improvement from product mix and operational leverage. This results-driven guidance is the immediate catalyst behind intraday buying and analyst upgrades.

The company also announced a quarterly dividend of $0.085 per share, reinforcing shareholder-return messaging while preserving capacity for R&D and buybacks.

CGNX stock valuation and key financials

CGNX trades with a market cap of $9.85 billion, EPS $0.68 (TTM) and a P/E of 86.46. Price-to-sales sits near 9.91 and price-to-book near 6.59. Free cash flow per share is $1.28 (TTM) and the company shows a current ratio of 3.80, indicating a strong balance sheet.

High multiples reflect expected AI-driven growth in machine vision. Investors should compare valuation to software and industrial peers in the Technology sector to judge whether margins and growth justify the premium.

CGNX stock technical snapshot and intraday action

Intraday range is $56.01–$59.54 with the day open at $58.65 and prior close $58.67. Volume is 4,792,062, or 2.43x average, signaling heavy interest. Technical indicators show strong momentum: RSI 85.18 (overbought), MACD histogram 1.81, and ADX 31.60 (strong trend).

Short-term traders should note a stretched setup. Support sits near the 50-day average $39.06 and resistance near the 52-week high $59.88. High RSI and MFI warn of potential pullbacks despite the bullish trend.

Meyka AI rates CGNX and model forecast

Meyka AI rates CGNX with a score out of 100: 72.42 (B+) — SUGGESTION: BUY. This grade factors in S&P 500 and sector comparison, financial growth, key metrics, analyst consensus and forecasts. This grade is informational and not investment advice.

Meyka AI’s forecast model projects a quarterly price of $36.81 and a yearly price of $30.64, compared with the current price $58.79. That implies a short-term downside of -37.39% to the quarterly projection and -47.90% to the yearly projection. Forecasts are model-based projections and not guarantees. Investors should balance model outputs with analyst targets and recent guidance.

Analyst targets, insider moves and market context

Analysts have become more mixed but generally bullish. Recent targets range from $45.00 to $67.00, with an average street target near $50.73. Needham lifted its target to $67.00 after the quarter, while other firms kept conservative marks. Insider sales were reported on Feb 12, reducing some near-term sentiment strength.

Sector context: machine vision sits at the intersection of industrial automation and AI. Strong enterprise adoption can lift revenue, but regulatory talk around AI and execution on margin expansion are key watchpoints. See coverage from MarketBeat and a deeper analysis on Seeking Alpha.

Risks and catalysts for CGNX stock outlook

Primary catalysts include continued revenue beats, margin expansion from product mix, and successful buyback/dividend execution. Broader AI adoption in manufacturing and logistics is a multi-year tailwind.

Key risks are stretched valuation, potential regulatory costs tied to AI deployments, and the impact of insider selling. Watch quarterly order trends, gross margins, and guidance for durable signs of a structural turnaround.

Final Thoughts

CGNX stock trades at $58.79 on 16 Feb 2026 after a Q4 beat and constructive guidance. Fundamentals show strong cash flow and a clean balance sheet, but valuation is rich with a P/E of 86.46 and price-to-sales near 9.91. Analyst targets cluster between $50.73 average and upside calls to $67.00. Meyka AI’s model projects $36.81 (quarter) and $30.64 (year), implying downside of -37.39% and -47.90% respectively versus the current price; these are model outputs, not guarantees. Given the mix of positive operational signals, heavy intraday volume (4,792,062), and a stretched technical setup (RSI 85.18), our view is that CGNX presents a high-conviction growth story with near-term volatility. Use exposure sizing and watch next earnings on 2026-04-29 for confirmation. For a deeper company page, see Meyka AI’s CGNX coverage at https://meyka.ai/stocks/CGNX.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.